Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutritional Ketosis and Alcohol Metabolism
NCT06065657Phase 3Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 3, randomised trial (3 arms), sponsored by University of Pennsylvania. Primary endpoint: Breath alcohol concentration at 3 hours. Started Feb 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06065657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06065657.